FROM MY PT SCHOOL NOTES · PEDIATRICS · CHAPTER 18
Genetic syndromes: clinical clues, not stereotypes
The syndrome presentations are best used as a clinical recognition atlas: identify the systems that need attention and the questions to ask, not a rigid profile that every child must fit.
Organize by safety and function
The source collection includes conditions with congenital heart disease, hearing or vision changes, bone/connective tissue risks, progressive neurologic disease, feeding concerns, and characteristic motor-development differences. Begin with medical risks and the child's current function.
A syndrome name is not a PT treatment plan
Two children with the same genetic diagnosis can have very different ability, endurance, communication, orthopedic alignment and goals. The medical team confirms diagnosis and manages syndrome-specific surveillance; PT contributes movement examination and participation planning.
Handle old terminology with care
Several 2019 student-created presentations contain dated gene lists, life-expectancy figures or terminology. For example, the older name "Hallervorden-Spatz" should be replaced by the modern disease name pantothenate kinase-associated neurodegeneration (PKAN) where appropriate. Do not repeat outdated prevalence or prognosis as current fact.
Try a clinical decision
A syndrome source lists an associated congenital heart condition. What changes for a PT evaluation?
Confirm the individual child's actual cardiac history and activity precautions, then tailor observation and functional testing. A syndrome association is a screening prompt, not proof of disease.
Original class sources: Achondroplasia.pdf, Angelman syndrome.pdf, EHLERS DANLOS SYNDROME.pdf, Hallervorden Spatz .pdf, Rett syndrome .pdf, Usher.pdf, Williams Syndrome.pdf, and 20 other condition presentation PDFs
This is a focused summary from personal PT-school notes, not a substitute for medical evaluation, an instructor course or a current clinical guideline.
